T cell responses to bacterial infection

Current Opinion in Immunology

Volumn 11, Issue 4, 1999, Pages 400-405

  Kerksiek, Kristen M ^a   Pamer, Eric G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CYTOKINE; VACCINE;

BACTERIAL IMMUNITY; BACTERIAL INFECTION; BORRELIA BURGDORFERI; CELLULAR IMMUNITY; HUMAN; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYME DISEASE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; T LYMPHOCYTE;

EID: 0033178358     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)80067-3     Document Type: Article

References (77)

1. Ladel CH, Flesch IEF, Arnoldi J, Kaufmann SHE: Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J Immunol 1994, 153:3116-3122.
2. Pamer EG, Sijts AJAM, Villanueva MS, Busch DH, Vijh S: MHC class I antigen processing of Listeria monocytogenes proteins: Implications for dominant and subdominant CTL responses. Immunol Rev 1997, 158:129-136.
3. Busch DH, Bouwer AGA, Hinrichs D, Pamer EG: A nonamer peptide derived from Listeria monocytogenes metalloprotease is presented to cytolytic T lymphocytes. Infect Immun 1997, 65:5326-5329.
4. Gulden PH, Fischer P, Sherman NE, Wang W, Engelhard VH, Shabanowitz J, Hunt DH, Pamer EG: A Listeria monocytogenes pentapeptide is presented to cytolytic T lymphocytes by the H2-M3 MHC class Ib molecule. Immunity 1996, 5:73-79.
5. Lenz LL, Dere B, Bevan MJ: Identification of an H2-M3-restricted Listeria epitope: Implications for antigen presentation by M3. Immunity 1996, 5:63-72.
6. Princiotta MF, Lenz LL, Bevan MJ, Staerz UD: H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med 1998, 187:1711-1720. This manuscript describes the identification of the third Listeria-derived N-formylated peptide that is presented by H2-M3. Interestingly, this epitope is derived from a leader peptide encoded by a transcriptional attenuator.
7. Safley SA, Cluff CW, Marshall NE, Ziegler HK: Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes: Identification of T cell epitopes of LLO. J Immunol 1991, 146:3604-3616.
8. + T cells specific for the major CTL antigen p60 can also provide protective immunity.
9. Sanderson S, Campbell DJ, Shastri N: Identification of a CD4+ T cell-stimulating antigen of pathogenic bacteria by expression cloning. J Exp Med 1995, 182:1751-1757.
10. Campbell DJ, Shastri N: Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes. J Immunol 1998, 161:2339-2347.
11. + T cells to intracellular bacteria. Curr Opin Immunol 1999, 11:89-93.
12. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SHE: Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci USA 1996, 93:1458-1463.
13. Hess J, Dietrich G, Gentschev I, Miko D, Goebel W, Kaufmann SHE: Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect Immun 1997, 65:1286-1292.
14. Shen H, Miller JF, Fan X, Kolwyck D, Ahmed R, Harty JT: Compartmentalization of bacterial antigens: Differential effects on priming of CD8 T cells and protective immunity. Cell 1998, 92:535-545. This manuscript describes a careful analysis of the effect of bacterial antigen secretion or retention on the induction of protective immunity.
15. Darji A, Bruder D, Lage SZ, Gerstel B, Chakraborty T, Wehland J, Weiss S: The role of the bacterial membrane protein ActA in immunity and protection against Listeria monocytogenes. J Immunol 1998, 161:2414-2420. Using L. monocytogenes strains that secrete ActA, these authors demonstrate the importance of secretion of antigen for protective immunity.
16. Villanueva MS, Sijts AJAM, Pamer EG: Listeriolysin is processed efficiently into an MHC class I-associated epitope in Listeria monocytogenes-infected cells. J Immunol 1995, 155:5227-5233.
17. Marquis H, Goldfine H, Portnoy DA: Proteolytic pathways of activation and degradation of a bacterial phospholipase C during intracellular infection by Listeria monocytogenes. J Cell Biol 1997, 137:1381-1892.
18. Moors MA, Levitt B, Youngman P, Portnoy DA: Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect Immun 1999, 67:131-139.
19. Vijh S, Pilip IM, Pamer EG: Non-competitive expansion of CTL specific for different antigens during bacterial infection. Infect Immun 1999, 67:1303-1309.
20. Bouwer HG, Shen H, Fan X, Miller JF, Barry RA, Hinrichs DJ: Existing antilisterial immunity does not inhibit the development of a Listeria monocytogenes-specific primary cytotoxic T-lymphocyte response. Infect Immun 1999, 67:253-258.
21. Busch DH, Pilip IM, Vijh S, Pamer EG: Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998, 8:353-362. This study demonstrates the remarkable synchrony of T cells responding to different antigens but the same bacterial pathogen.
22. Busch DH, Pilip I, Pamer EG: Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med 1998, 188:61-70.
23. 91-99 undergo TCR focusing with an increase in their affinity for antigen.
24. Braud VM, Allen DSJ, McMichael AJ: Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 1999, 11:100-108.
25. Bouwer HG, Seaman MS, Forman J, Hinrichs DJ: MHC class Ib restricted cells contribute to antilisterial immunity: Evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J Immunol 1997, 159:2795-2801.
26. Bouwer HGA, Bai A, Forman J, Gregory SH, Wing EJ, Barry RA, Hinrichs DJ: Listeria monocytogenes-infected hepatocytes are targets of major histocompatibility complex class Ib-restricted antilisterial cytotoxic T lymphocytes. Infect Immun 1998, 66:2814-2817.
27. Lenz LL, Bevan MJ: CTL responses to H2-M3-restricted Listeria epitopes. Immunol Rev 1997, 158:115-121.
28. Nataraj C, Huffman GR, Kurlander RJ: H2M3wt-restricted, Listeria monocytogenes-immune CD8 T cells respond to multiple formylated peptides and to a variety of Gram-positive and Gram-negative bacteria. Int Immunol 1998, 10:7-15. These authors demonstrate that H2-M3-restricted T cells are remarkably promiscuous with respect to peptide recognition.
29. Kerksiek KM, Busch DH, Pilip IM, Allen SE, Pamer EG: H2-M3 restricted T cells in bacterial infection: Rapid primary but diminished memory responses. J Exp Med 1999, in press.
30. Harty JT, Bevan MJ: Specific immunity to Listeria monocytogenes in the absence of IFN-gamma. Immunity 1995, 3:109-118.
31. + T cells to protect even if they cannot secrete IFN-γ.
32. Stenger S, Modlin RL: Cytotoxic T cell responses to intracellular pathogens. Curr Opin Immunol 1998, 10:471-477.
33. Kagi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RF: CD8 T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol 1994, 24:3068-3072.
34. Jensen ER, Glass AA, Clark WR, Wing EJ, Miller JF, Gregory SH: Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes. Infect Immun 1998, 66:4143-4150.
35. + T cells depends upon the activities of TNF-α.
36. White DW, MacNeil A, Busch DH, Pilip IM, Pamer EG, Harty JT: Perforin-deficient CD8+ T cells: In vivo priming and antigen-specific immunity against Listeria monocytogenes. J Immunol 1999, 162:980-988.
37. Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melian A, Bogdan C et al.: An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998, 282:121-125. This study demonstrates that granulysin, a secreted product of CTLs, can kill a variety of bacteria. This finding is important because it directly links T cells with microbial destruction.
38. Schaible UE, Collins HL, Kaufmann SHE: Confrontation between intracellular bacteria and the immune system. Adv Immunol 1999, 71:267-377.
39. Geluk A, Taneja V, Meijgaarden KEV, Zanelli E, Abou-Zeid C, Thole JER, Vries RRPD, David CS, Ottenhoff THM: Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc Natl Acad Sci USA 1998, 95:10797-10802. These authors show that mice expressing human MHC molecules can be used to identify antigens derived from important pathogens.
40. Lewinsohn DM, Alderson MR, Briden AL, Riddell SR, Reed SG, Grabstein KH: Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998, 187:1633-1640.
41. Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH: Activation of human CD8+ αβ TCR+ cells by mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol 1999, 162:372-379.
42. Lalvani A, Brookes R, Wilkinson RJ, Malin AS, Pathan AA, Anderson P, Dockreil H, Pasvol G, Hill AVS: Human cytolytic and interferon γ-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998, 95:270-275.
43. Mohagheghpour N, Gammon D, Kawamura LM, Vollenhoven AV, Benike CJ, Engleman EG: CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998, 161:2400-2406.
44. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR: Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992, 89:12013-12017.
45. Tan JS, Canaday DH, Boom WH, Balaji KN, Schwander SK, Rich EA: Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: Role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J Immunol 1997, 159:290-297.
46. Porcelli SA: The CD1 family: A third lineage of antigen-presenting molecules. Adv Immunol 1995, 59:1-98.
47. Stenger S, Mazzaccaro RJ, Uyemura K, Cho S, Barnes PF, Rosat J-P, Sette A, Brenner MB, Porcelli SA, Bloom BR, Modlin RL: Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687.
48. Rosat J-P, Grant EP, Beckman EM, Dascher CG, Sieling PA, Frederique D, Modlin RL, Porcelli SA, Furlong ST, Brenner MB: CD1 -restricted microbial lipid antigen-specific recognition found in the CD8+ αβ T cell pool. J Immunol 1999, 162:366-371.
49. Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA: The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 1998, 8:341 -351. This study defines a tyrosine containing motif that determines intracellular targeting of CD1b.
50. Laochumroonvorapong P, Wang J, Liu C-C, Ye W, Moreira AL, Elkon KB, Freedman VH, Kaplan G: Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997, 65:127-132.
51. Cooper AM, D'Sousa C, Frank AA, Orme IM: The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997, 65:1317-1320.
52. Bellamy R, Hill AV: Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr Opin Immunol 1998, 10:483-487.
53. Altare F, Durandy A, Lammas D, Emile J-F, Lamhamedi S, Deist FL, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F et al.: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998, 280:1432-1435. The important role of IL-12 for T cell mediated immunity to mycobacteria and Salmonella infections is demonstrated in this study, along with [54•], of patients with defects in the IL-12 receptor.
54. Jong RD, Altare F, Haagen I-A, Elferink DG, Boer TD, Vriesman PJCVB, Kabel PJ, Draaisma JMT, Dissel JTV, Kroon FP et al.: Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998, 280:1435-1438. See annotation [53••].
55. Cooper AM, Magram J, Ferrante J, Orme IM: Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997, 186:39-45.
56. Wakeham J, Wang J, Magram J, Croitoru K, Harkness R, Dunn P, Zganiacz A, Xing Z: Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis Bacille Calmette-Guerin in IL-12-deficient mice. J Immunol 1998, 160:6101-6111.
57. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z: In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β. Proc Natl Acad Sci USA 1997, 94:3926-3931.
58. Busch DH, Jassoy C, Brinckmann U, Girschick H, Huppertz HI: Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis. J Immunol 1996, 157:3534-3541.
59. Dong Z, Edelstein MD, Glickstein LJ: CD8+ T cells are activated during the early Th1 and Th2 immune responses in a murine lyme disease model. Infect Immun 1997, 65:5334-5337.
60. Keane-Myers A, Nickell SP: T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995, 154:1770-1776.
61. Matyniak JE, Reiner SL: T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995, 181:1251-1254.
62. Keane-Myers A, Nickell SP: Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995, 155:2020-2028.
63. Anguita J, Rincon M, Samata S, Barthold SW, Flavell RA, Fikrig E: Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis 1998, 178:1512-1515.
64. Gross DM, Steere AC, Huber BT: T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998, 160:1022-1028.
65. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998, 281:703-706. This provocative study suggests that chronic Lyme arthritis following infection with B. burgdorferi may result from antigenic mimicry.
66. Pohl-Koppe A, Balashov KE, Steere AC, Logigian EL, Hafler DA: Identification of a T cell subset capable of both IFN-γ and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol 1998, 160:1804-1810.
67. Fikrig E, Barthold SW, Chen M, Chang C-H, Flavell RA: Protective antibodies develop, and murine lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J Immunol 1997, 159:5682-5686.
68. Weiskirch LM, Paterson Y: Listeria monocytogenes: A potent vaccine vector for neoplastic and infectious disease. Immunol Rev 1997, 158:159-169.
69. Jensen ER, Shen H, Wettstein FO, Ahmed R, Miller JF: Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity. Immunol Rev 1997, 158:147-157.
70. Dietrich G, Bubert A, Gentschev I, Sokolovic Z, Simm A, Catic A, Kaufmann SHE, Hess J, Szalay AA, Goebel W: Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol 1998, 16:181-185. This study uses a very clever approach to release DNA from L. monocytogenes into the cytosol of infected cells.
71. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S: Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 1997, 91:765-775.
72. Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, Galan JE, Aizawa S-I: Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 1998, 280:602-605.
73. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, Donis RO: Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 1998, 281:565-568. These authors show that the Salmonella type III secretion system can be exploited to deliver antigens to the MHC class I antigen processing pathway.
74. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SHE: Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA 1998, 95:5299-5304.
75. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J et al.: Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nat Biotechnol 1999, 17:37-41.
76. VanCott JL, Chatfield SN, Roberts M, Hone DM, Hohmann EL, Pascual DW, Yamamoto M, Kiyono H, McGhee JR: Regulation of host immune responses by modification of Salmonella virulence genes. Nat Med 1998, 4:1247-1252.
77. Medina E, Paglia P, Nikolaus T, Muller A, Hensel M, Guzman CA: Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect Immun 1999, 67:1093-1099.